Spark Investment Management’s Travere Therapeutics TVTX Stock Holding History

Spark Investment Management’s Portfolio TVTX Stock Details TVTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-92,800	Closed	-$1.32M	–	532
2019 Q4	$1.32M	Hold	92,800	–	–	0.15%	189
2019 Q3	$1.07M	Sell	92,800 -53,300	-36%	-$881K	0.14%	182
2019 Q2	$2.94M	Sell	146,100 -172,800	-54%	-$3.41M	0.2%	156
2019 Q1	$7.22M	Buy	318,900 +32,100	+11%	+$709K	0.33%	89
2018 Q4	$6.49M	Buy	286,800 +22,900	+9%	+$570K	0.45%	64
2018 Q3	$7.58M	Hold	263,900	–	–	0.43%	52
2018 Q2	$7.19M	Hold	263,900	–	–	0.42%	59
2018 Q1	$5.9M	Sell	263,900 -63,900	-19%	-$1.52M	0.38%	74
2017 Q4	$6.91M	Buy	327,800 +38,500	+13%	+$880K	0.37%	71
2017 Q3	$7.2M	Buy	289,300 +12,190	+4%	+$268K	0.39%	75
2017 Q2	$5.37M	Hold	277,110	–	–	0.33%	86
2017 Q1	$5.12M	Buy	277,110 +120,610	+77%	+$2.36M	0.32%	77
2016 Q4	$2.96M	Sell	156,500 -72,200	-32%	-$1.48M	0.24%	127
2016 Q3	$5.12M	Sell	228,700 -76,600	-25%	-$1.46M	0.41%	57
2016 Q2	$5.44M	Sell	305,300 -88,000	-22%	-$1.42M	0.51%	34
2016 Q1	$5.37M	Buy	393,300 +153,800	+64%	+$2.33M	0.54%	24
2015 Q4	$4.62M	Buy	239,500 +46,100	+24%	+$921K	0.59%	25
2015 Q3	$3.91M	Buy	193,400 +103,900	+116%	+$3.08M	0.51%	37
2015 Q2	$2.97M	Buy	+89,500	New	+$2.45M	0.41%	59

Other funds holding TVTX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Spark Investment Management's TVTX Position: Q1 2020 in Review

Spark Investment Management sold out of Travere Therapeutics (TVTX) in Q1 2020, closing a stake of 92,800 shares — an estimated $1.32M sold.

Spark Investment Management first reported a position in TVTX in Q2 2015 and held it in 19 quarters. The position peaked at $7.58M in Q3 2018. 124 funds tracked by Wall St. Rank hold TVTX as of Q1 2020.

Spark Investment Management reported no remaining Travere Therapeutics position as of Q1 2020 after selling out during the quarter.
Spark Investment Management sold 92,800 Travere Therapeutics shares in Q1 2020, an estimated $1.32M.
Spark Investment Management first reported a position in Travere Therapeutics in Q2 2015 and held it in 19 quarters.
Spark Investment Management's Travere Therapeutics position peaked at $7.58M in Q3 2018.
124 funds tracked by Wall St. Rank held Travere Therapeutics as of Q1 2020.

Based on Spark Investment Management's 13F filing for Q1 2020, filed 12 May 2020.